- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Listen to the Latest ‘KFF Health News Minute’
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
Most of Michigan isn't so sure what's wrong with corporate welfare, especially when their town gets a "free" grant.
But we should ask ourselves: how cozy are the Swamp and Corporate Welfare - cozy, identical, or just co-dependent?
Here's a Michigan Primer to get you started, courtesy The Midwesterner News.
@ColinJoyce
Rep. DeBoyer: MEDC hiding SOAR corporate welfare failures by renegotiating contracts
Government investment handout thus far expected to total $10.2 billion
After spending nearly $3 billion over the last dozen years, the Michigan Economic Development Corporation is working to claw back about $21.9 million in failed corporate welfare deals.
So far, the agency headed by appointees of Gov. Gretchen Whitmer has recovered roughly $18.3 million, though the MEDC is shielding other failures by renegotiating some of its biggest taxpayer-funded incentives when companies fail to meet hiring and investment metrics, according to The Detroit News.
“I think it’s important to recognize, instead of acknowledging failures, they just renegotiate the contract on what they’re able to accomplish,” state Rep. Jay DeBoyer, the Clay Twp. Republican chair of the House Oversight Committee, told the news site. “Imagine doing that with your kid when it comes to doing their chores.”
The data follows a request from DeBoyer earlier this month as his committee works to assess the performance of the state’s largest business incentive programs, which Whitmer and select lawmakers have leveraged to court big business, much of it centered on the electric vehicle industry.
The review is part of a broader effort by House Republicans to shift funding from the taxpayer-funded corporate subsidies to fulfill Whitmer’s campaign promise to “fix the damn roads.”
Records show the Michigan Business Development Program, launched in 2012, has provided 271 businesses a total of $289.8 million in incentives for an expected investment of $10.2 billion.
Sixty-two or 23% of those deals were canceled or are in repayment because grantees did not fulfill their requirements, while another 21 are in default or have declared bankruptcy. Sixty-seven, or about a quarter, were contracted last year, according to records reviewed by The News.
MEDC has identified $21.9 million in clawbacks for that program, and has collected $18.3 million so far, the MEDC told DeBoyer.
A separate Michigan Community Revitalization Program that also launched in 2012 has doled out another $365 million for 172 grants and loans to incentivize private investment in historic or brownfield sites, and the MEDC report does not detail if any are in default.
A third business incentive program created by lawmakers in 2021 known as the Strategic Outreach and Attraction Reserve committed another $2.8 billion to court massive investments in the EV and renewable energy industries. While both Ford and General Motors, the two biggest beneficiaries of SOAR funds, have scaled back their investments, Whitmer’s MEDC has not worked to claw back the funds, opting instead to renegotiate those contracts, corporation spokesman Otie McKinley told The News.
“There have been no clawback provisions triggered for SOAR projects to date,” McKinley said. “In some cases, awards have not yet been fully disbursed.”
“These latest developments underscore what I’ve been saying all along — projects like this require much stricter oversight,” said state Rep. Sarah Lightner, R-Springport. “We must have safeguards in place to protect taxpayers from financial risks and national security threats. If a project is tanking, or it turns out to have ties to a questionable company, we need the ability to claw back those funds and redirect them to better uses.”
Ford’s decision was followed by GM’s announcement in December it’s backing out of a joint venture with South Korea-based LG Energy Solution for a $2.5 billion Ultium Cells battery plant near Lansing that came with a $120 million SOAR grant.
MEDC officials ultimately cut Ford’s taxpayer cash from about $1.75 billion to between $384 and $409 million, depending on the number of jobs created, according to Bridge Michigan.
MEDC paid out GM’s SOAR grant in 2023, well before any jobs were created, and last week voted not to claw back the funding, opting instead to transfer the obligation to create 1,360 jobs to LG.
Other SOAR deals are also poised to flop, with CCP-linked Gotion, Inc. CEO Chuck Thelen announcing on Friday he halted the state permitting process to build the Gotion EV battery component plant in Mecosta County amid litigation over its fate.
Like GM and Ford, Gotion landed $715 million in taxpayer incentives from the SOAR program through secretly negotiated agreements with Whitmer’s MEDC and select lawmakers in 2022, before widespread opposition over the company’s ties to communist China derailed its plans.
The struggles at MEDC are nothing new.
A broader analysis of corporate incentive deals in Michigan from 2000 to 2020 found that out of a total of 123,060 new jobs promised, a mere 10,889 actually materialized, a success rate of just 9%.
“Only one in 11 of the announced jobs in these front page stories ever came to fruition,” according to Front Page Failures, released by the Mackinac Center for Public Policy in December 2024.
Another analysis of the first $1 billion in SOAR grant money spent found similar results, with Bridge Michigan identifying the creation of a total of 200 out of 12,000 promised jobs as of mid-June 2024.
MEDC officials argue the SOAR program hasn’t yet matured enough to effectively analyze whether it’s meeting its goal of attracting and retaining jobs in Michigan, but Boyer and his oversight committee aren’t buying it.
“The private sector measures their earnings matrix on a quarterly basis and you’re telling me the government can’t measure its matrix years down the road?” DeBoyer said. “That is messaging to conceal failures.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















